Sterling
Pfizer logo
Pfizer
Viking Therapeutics logo
Viking Therapeutics

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Pfizer 15.034, Viking Therapeutics 0.

Pfizer vs Viking Therapeutics Net Worth and Market Cap

Pfizer (PFE) and Viking Therapeutics (VKTX) are peers in GLP-1. Pfizer reported revenue of $15.0B as of Q2 2026, compared with $0 for Viking Therapeutics. Pfizer leads on revenue.

Key differences

  • Pfizer's KPIs on Sterling include Abrysvo Revenues by Region (Quarterly) and Comirnaty Revenues by Region (Quarterly).
  • Viking Therapeutics's KPIs on Sterling include Cash + Short-Term Investments (Quarterly) and Viking Oral VK2735 Phase 3 Timing.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, Viking Therapeutics.
MetricPfizerViking Therapeutics
Market Cap--
Revenue$15.03B$0
Cost of Revenue$4.09B$0
Gross Profit$10.94B$0
Operating Income$4.71B$-164.00M
Net Income$-246.00M$-158.00M
R&D Expense$2.81B$150.00M
Earnings Per Share-$0.04-$1.37
Gross Margin72.8%-
Operating Margin31.3%-
Net Profit Margin-1.6%-
Free Cash Flow$302.00M$-114.00M
Cumulative Free Cash Flow$356.70B$-747.00M
Operating Cash Flow$835.00M$-114.00M
Cash & Equivalents$976.00M$118.00M

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites